Policies & Procedures

Procedures
Social Media Procedures Social Media Procedures (10/2017)
NCORP Concept Submission NCORP Concept Submission (2/2018)
Survey Procedures See Policy 49: Member Surveys (4/2022)
Survey Review Request Form See Policy 49: Member Surveys  (4/2022)

Manuals
ORP Manual ORP Manual (3/2022)

Policies
Policy 01 SWOG Mission Statement (4/2018)
Policy 02 Constitution/ByLaws (5/2023)
Policy 03 Guidelines for Full Group Institutional Members in SWOG (10/2018)
Policy 04 National Community Oncology Research Program Guidelines (10/2018)
Policy 05 Affiliate Program Membership (4/2012)
Policy 06 Policy Deleted (no download available)
Policy 07 Individual Membership Process (10/2022)
Policy 08 Committee Membership Nominations (10/2022)
Policy 09 Investigator/Clinical Research Associate/Nurse Contribution Sheets (5/2013)
Policy 10 Job Description of Disease and Research Committee Chair (10/2018)
Policy 11 Job Description of a Study Chair (10/2022)
Policy 12 SWOG Registration and Treatment Policies (9/2020)
Policy 13 Protocol Guidelines (10/2022)
Policy 14 Policy Deleted (no download available)
Policy 15 Applicability of IND Applications and Investigator Brochures/Support From Pharmaceutical Companies (4/2011)
Policy 16 Policy Deleted (no download available)
Policy 17 Cost Containment (5/2013)
Policy 18 Data Evaluation Policy and Procedure (9/2020)
Policy 19 Quality Assurance Program (9/2020)
Policy 20 New Agent Studies and Safety Monitoring (5/2015)
Policy 21 Data and Safety Monitoring (5/2013)
Policy 22 Ethical and Regulatory Considerations (4/2018)
Policy 23 Serious Adverse Events (10/2022)
Policy 24 Procedural Guidelines for All SWOG Publications (10/2023)
Policy 25 Drug Ordering (4/2022)
Policy 26 The SWOG Radiation Therapy Quality Assurance Committee (4/2019)
Policy 27 Bone Marrow and Stem Cell Transplantation Guidelines for Institution Approval (5/2014)
Policy 28 Policy Deleted (no download available)
Policy 29 Roster of Institutions, Investigators and Associates Maintenance Policies and Procedures (10/2022)
Policy 30 Responsibility for Patient Follow-Up (8/2023)
Policy 31 HIPAA Privacy Rule Policy (4/2022)
Policy 32 Policy deleted (no download available)
Policy 33 Institutional Performance Review (10/2017)
Policy 34 Industrial Interaction (5/2013)
Policy 35 Financial Conflict of Interest Policy (10/2023)
Policy 36 Affirmation of Integrity (9/2020)
Policy 37 Policy deleted (no download available)
Policy 38 Research Calculations for Clinical Trials (10/2021)
Policy 39 Acquisition, Maintenance and Use in Research of Tissue and Other Biologic Patient Specimens (5/2014)
Policy 40 Membership of Non-United States Institutions (5/2023)
Policy 41 Debarment, Suspension or Other Administrative Actions & Handling of Allegations of Research Misconduct (9/2020)
Policy 42 Policy on Advertising for Subject Recruitment and Trial Promotion (4/2019)
Policy 43 Requests for Patient Data from Investigators and Pharmaceutical Companies (10/2019)
Policy 44 Early Closure of Studies (10/2007)
Policy 45 Press Releases and Trial Publicity (4/2019)
Policy 46 Job Description of a Principal Investigator (10/2023)
Policy 47 Intellectual Property Policy (10/2012)
Policy 48 Job Description of Translational Medicine Subcommittee Chair (5/2013)
Policy 49 Member Surveys (4/2022)
Policy 50 Description and Responsibilities of a SWOG Lead Oncology Research Professional (10/2023)